Matches in Nanopublications for { ?s ?p "[Treating hepatoma cells with 2-AAF activated phosphoinositide 3-kinase (PI3K) and its downstream effectors Rac1, and NAD(P)H oxidase.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP262680.RATfGTG9y6xy_WxzYrCoI8sw-xerutL48Ov35HmQfQPZU130_assertion description "[Treating hepatoma cells with 2-AAF activated phosphoinositide 3-kinase (PI3K) and its downstream effectors Rac1, and NAD(P)H oxidase.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP262680.RATfGTG9y6xy_WxzYrCoI8sw-xerutL48Ov35HmQfQPZU130_provenance.
- NP613235.RAD5rI8AZ6gMdRGdbFqFESgO_mmuwF1JH0mqGOPMsPfm8130_assertion description "[Treating hepatoma cells with 2-AAF activated phosphoinositide 3-kinase (PI3K) and its downstream effectors Rac1, and NAD(P)H oxidase.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP613235.RAD5rI8AZ6gMdRGdbFqFESgO_mmuwF1JH0mqGOPMsPfm8130_provenance.
- NP527423.RAi4C-CcwBO3nlxsFdKPfHMgxbZ0lBAIUz0Uonk1dd5QM130_assertion description "[Treating hepatoma cells with 2-AAF activated phosphoinositide 3-kinase (PI3K) and its downstream effectors Rac1, and NAD(P)H oxidase.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP527423.RAi4C-CcwBO3nlxsFdKPfHMgxbZ0lBAIUz0Uonk1dd5QM130_provenance.
- NP856545.RASg9ynSkJRydnWv2FdWv9Gf6Iew3EkvVjXv2yoZrUf4U130_assertion description "[Treating hepatoma cells with 2-AAF activated phosphoinositide 3-kinase (PI3K) and its downstream effectors Rac1, and NAD(P)H oxidase.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP856545.RASg9ynSkJRydnWv2FdWv9Gf6Iew3EkvVjXv2yoZrUf4U130_provenance.
- NP495654.RA84mT9TD-6kV6X5T1QWplDs9WcTXAY3g7KRhH2ojQKIo130_assertion description "[Treating hepatoma cells with 2-AAF activated phosphoinositide 3-kinase (PI3K) and its downstream effectors Rac1, and NAD(P)H oxidase.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP495654.RA84mT9TD-6kV6X5T1QWplDs9WcTXAY3g7KRhH2ojQKIo130_provenance.
- NP301904.RAwYYpIOFyLbvaLaRF3P2Dn5X68ANw1msPJJ98cuBXhNE130_assertion description "[Treating hepatoma cells with 2-AAF activated phosphoinositide 3-kinase (PI3K) and its downstream effectors Rac1, and NAD(P)H oxidase.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301904.RAwYYpIOFyLbvaLaRF3P2Dn5X68ANw1msPJJ98cuBXhNE130_provenance.
- NP905086.RA8G7sSZZsH1AFAcZd7mbEN3OPQt3saaHOFhk3clT1_wg130_assertion description "[Treating hepatoma cells with 2-AAF activated phosphoinositide 3-kinase (PI3K) and its downstream effectors Rac1, and NAD(P)H oxidase.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905086.RA8G7sSZZsH1AFAcZd7mbEN3OPQt3saaHOFhk3clT1_wg130_provenance.
- NP676196.RAMvPk_pqLsoxil41FxiP87e4wsLuj5cnHl3mRX7EDNxA130_assertion description "[Treating hepatoma cells with 2-AAF activated phosphoinositide 3-kinase (PI3K) and its downstream effectors Rac1, and NAD(P)H oxidase.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP676196.RAMvPk_pqLsoxil41FxiP87e4wsLuj5cnHl3mRX7EDNxA130_provenance.